Baxter International Inc.

BAX Healthcare Medical Instruments & Supplies

Baxter International Inc.’s revenue for fiscal 2025 (year ended December 2025) was $11.2 billion, up 5.72% from fiscal 2024.

Revenue
+4.97%
EPS
+731.9%
Free cash flow
+255.6%
Total debt
−9.48%

Quarter to September 2026, against a year earlier

25.57 0.93 −3.51%
Market cap
$13.3B
P/E
0.0×
Fwd P/E
21.3×
Dividend yield
0.16%
F-score
4/9
Altman Z
2.12
Beneish M
−2.67
Dividend safety
0/100
Older periods Dec '25 Mar '26 Jun '26 Sep '26
P/E ratio

+8 more quarters

0.00 0.00 0.00 0.00
P/S ratio
0.87 0.76 0.96 1.07
P/FCF ratio
29.53 11.97 13.52 10.91
P/Operating CF
16.79 40.62 38.68 22.24
P/B ratio
1.61 1.44 1.78 1.92
EV/Sales
1.54 1.42 1.60 1.64
EV/EBITDA
11.96 11.13 12.61 12.61
EV/FCF
52.15 22.27 22.49 16.74
Current Ratio
2.31 1.85 1.95 1.79
Net Debt/EBITDA
26.26 24.57 16.03 14.28
Debt/Equity
1.55 1.57 1.53 1.33
Earnings Yield
(9.68%) (12.68%) (9.71%) (5.88%)
Free Cash Flow Yield
3.39% 8.36% 7.39% 9.16%
Free Cash Flow per Share
0.87 0.15 0.33 0.87
Book value per Share
11.89 11.68 11.95 12.52
Free Cash Flow
444.00 76.00 169.00 448.00
EV/EBIT
0.00 0.00 0.00 0.00
Other line items

Show all line items

Columns are period end dates · fundamentals updated 2 Nov 2026